| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |